Modifiable Risk Factors as Drivers of Pharmaceutical Expenditures Among US Adults with Atherosclerotic Heart Disease: 2012 Medical Expenditure Panel Survey

cited authors

  • Salami, Joseph A; Valero-Elizondo, Javier; Ogunmoroti, Oluseye; Spatz, Erica S; Rana, Jamal S; Virani, Salim S; Blankstein, Ron; Blaha, Michael J; Younus, Adnan; Arrieta, Alejandro; Veledar, Emir; Nasir, Khuram

fiu authors

date/time interval

  • March 1, 2016 -

publication date

  • March 1, 2016
  • March 1, 2016

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Cost-effectiveness
  • Health economics
  • Life Sciences & Biomedicine
  • Peripheral Vascular Disease
  • Pharmacy
  • Science & Technology

Location

  • Phoenix, AZ

WoS ID

  • 000381415500242

Conference

  • Scientific Sessions of the American-Heart-Association on Epidemiology and Prevention/Lifestyle and Cardiometabolic Health

volume

  • 133